CP-339818

SynDRA canonical compound SYN0001346 — structure-anchored drug synonym record

Clinical phase	Preclinical
Primary target(s)	KCNA2 \| KCNA3 \| KCNA5 \| KCNAB2 \| KCNC1 \| KCNC2 \| KCNC3 \| KCNE1 \| KCNE2 \| KCNE3 \| KCNE4 \| KCNH1 \| KCNH2 \| KCNQ1 \| KCNQ2 \| KCNQ3 \| KCNQ5 \| KCNS3
Mechanism of action	potassium channel blocker

All known targets

KCNA3
KCNA2
KCNQ5
KCNQ3
KCNQ2
KCNQ1
KCNH2
KCNH1
KCNE4
KCNE3
KCNE2
KCNE1

Mechanisms of action (all sources)

potassium channel blocker
KCNA3 INHIBITOR

Cross-references

PubChem CID: 656767
ChEMBL: CHEMBL281622
ChEBI: 34602
TTD: D0E9MC

Synonyms

CP 339818
CHEMBL281622
AC1LCVJB
Tocris-1399
C13847
(1-Benzyl-1H-quinolin-4-ylidene)-pentyl-amine
SureCN12648579
GTPL2558
SCHEMBL12648579
CHEBI:34602
1-benzyl-N-pentylquinolin-4-imine
1-benzyl-N-pentyl-quinolin-4-imine
ZINC17919916
BDBM50083523
ZINC100002080
ZINC253533285
NCGC00025144-01
AJ-70179
CP339818
AJ-70180
N-pentyl-1-(phenylmethyl)quinolin-4-imine

Look up CP-339818 in the interactive SynDRA portal →